Authors:
O'Neill, MJ
Murray, TK
McCarty, DR
Hicks, CA
Dell, CP
Patrick, KE
Ward, MA
Osborne, DJ
Wiernicki, TR
Roman, CR
Lodge, D
Fleisch, JH
Singh, J
Citation: Mj. O'Neill et al., ARL 17477, a selective nitric oxide synthase inhibitor, with neuroprotective effects in animal models of global and focal cerebral ischaemia, BRAIN RES, 871(2), 2000, pp. 234-244
Authors:
Snyder, DW
Bach, NJ
Dillard, RD
Draheim, SE
Carlson, DG
Fox, N
Roehm, NW
Armstrong, CT
Chang, CH
Hartley, LW
Johnson, LM
Roman, CR
Smith, AC
Song, M
Fleisch, JH
Citation: Dw. Snyder et al., Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy]acetate, a potent and selective secretory phospholipase A(2) inhibitor: A new class of anti-inflammatory drugs, SPI, J PHARM EXP, 288(3), 1999, pp. 1117-1124
Citation: Wt. Jackson et al., Pharmacologic actions of the second-generation leukotriene B-4 receptor antagonist LY293111: In vitro studies, J PHARM EXP, 288(1), 1999, pp. 286-294